# Imagenomix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/imagenomix

- Industry: Biotechnology
- Headquarters: New York, US
- Website: https://imagenomix.ai
- Total disclosed funding: $3.2M
- Latest round: Seed (May 8, 2026)
- Investors on record: 3

## About

Based in New York, US, Imagenomix specializes in advanced artificial intelligence solutions that optimize image analysis and processing across various sectors, including healthcare and retail.Imagenomix is dedicated to enhancing image analysis through innovative AI technology. The company is co-founded by Daniel Orringer, Matija Snuderl, Aris Tsirigos, with a vision to improve image processing efficiencies, the company is headquartered in New York, US, and was incorporated in 2022. The company raised USD 3.2 mn in Seed funding on May 8, 2026, marking a significant milestone as it continues to grow in the AI sector.Imagenomix.ai specializes in advanced artificial intelligence solutions aimed at optimizing image analysis and processing across various industries. Their core product offerings include machine learning algorithms that enhance image recognition capabilities, particularly in fields such as healthcare, security, and retail. These solutions are designed to address specific challenges such as improving diagnostic accuracy in medical imaging, enhancing surveillance systems, and automating inventory management through visual recognition. The company targets a diverse clientele, including hospitals, security firms, and e-commerce retailers, serving markets primarily in North America, Europe, and parts of Asia. The products are tailored to ensure they meet the unique needs of these sectors, providing robust functionality and ease of integration with existing systems.Imagenomix.ai generates revenue through a structured model that includes subscription-based services and direct partnerships with businesses. Clients typically engage in annual or multi-year subscription agreements that grant access to the company’s proprietary image analysis technologies, including their flagship product, which leverages algorithms for high-efficiency processing. Transactions often involve customized pricing plans based on the scale of usage and specific service implementations required by the clients. Additionally, the company may enter into B2B partnerships that facilitate broader distribution of its technologies through integrators and resellers, enhancing market penetration. Revenue is thus derived from a combination of ongoing service fees associated with these subscriptions and partnership-driven sales initiatives.In May 2026, Imagenomix raised USD 3.2 mn in Seed funding, which will be allocated to develop new AI-driven products aimed at expanding their capabilities in image analysis. The company plans to broaden its market presence in Europe and Asia by the end of 2027, targeting specific sectors like healthcare and e-commerce to leverage its existing technology. The funding will support these initiatives, ensuring a robust rollout of new solutions that cater to the evolving demands of the industry.

## Funding rounds

- Seed, May 8, 2026, $3.2M — NYU Venture Capital, Verge HealthTech, Modi Ventures

## Investors

- NYU Venture Capital (https://capitalatlas.ai/funds/nyu-venture-capital) — Seed
- Verge HealthTech (https://capitalatlas.ai/funds/verge-healthtech) — Seed
- Modi Ventures (https://capitalatlas.ai/funds/modi-ventures) — Seed